Familial Partial Lipodystrophy Overview
Learn About Familial Partial Lipodystrophy
Familial partial lipodystrophy is a rare condition characterized by an abnormal distribution of fatty (adipose) tissue. Adipose tissue is normally found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat as a source of energy and also provides cushioning. In people with familial partial lipodystrophy, adipose tissue is lost from the arms, legs, and hips, giving these parts of the body a very muscular appearance. The fat that cannot be stored in the limbs builds up around the face and neck, and inside the abdomen. Excess fat in these areas gives individuals an appearance described as "cushingoid," because it resembles the physical features associated with a hormonal disorder called Cushing disease. This abnormal fat distribution can begin anytime from childhood to adulthood.
Familial partial lipodystrophy can be caused by mutations in several genes. Type 2 results from mutations in the LMNA gene. The other, less common forms of the disorder are caused by mutations in different genes.
Familial partial lipodystrophy is a rare disease, affecting an estimated 1 in 1 million people overall. Type 2 is the most common form, with more than 500 cases reported in the medical literature. Women tend to be diagnosed with familial partial lipodystrophy more often than men, probably because a loss of fat from the hips and limbs is more easily recognized in women, and complications such as diabetes and hypertriglyceridemia occur more commonly in women.
Most cases of familial partial lipodystrophy, including type 2, are inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. In some cases, an affected person inherits the mutation from one affected parent. Other cases result from new mutations in the gene and occur in people with no history of the disorder in their family.
Regents Of The University Of Michigan
Elif Oral is an Endocrinologist in Ann Arbor, Michigan. Dr. Oral and is rated as an Elite provider by MediFind in the treatment of Familial Partial Lipodystrophy. Her top areas of expertise are Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is currently accepting new patients.
University Of Texas Southwestern Medical Center At Dallas
Abhimanyu Garg is an Endocrinologist in Dallas, Texas. Dr. Garg has been practicing medicine for over 43 years and is rated as an Elite provider by MediFind in the treatment of Familial Partial Lipodystrophy. His top areas of expertise are Acrorenal Mandibular Syndrome, Congenital Generalized Lipodystrophy, Familial Partial Lipodystrophy, Gastric Bypass, and Endoscopy.
Baris Akinci practices in Dokuz Eylul, Turkey. Mr. Akinci and is rated as an Elite expert by MediFind in the treatment of Familial Partial Lipodystrophy. His top areas of expertise are Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Gigantism, and Familial Hypertriglyceridemia.
Background: People with familial partial lipodystrophy (FPLD) do not store fat in the body normally. This can lead to serious illnesses such as diabetes and heart disease. To learn more about FPLD, researchers want to compare the fat tissue in people with this disease to the fat tissue of healthy people.
Summary: This Phase 3 study is an Open Label Extension of the APG-20 Study To Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects with Partial Lipodystrophy
Published Date: September 01, 2016
Published By: National Institutes of Health